CJC-1295 + Ipamorelin is a two-component research blend combining CJC-1295 no-DAC, also known as modified GRF(1-29), with the selective growth hormone secretagogue peptide Ipamorelin. Laboratory literature discusses these components in relation to GHRH receptor activity, ghrelin receptor pathway models, endocrine pulsatility research, and peptide structure-function studies.
This blend is intended for controlled analytical and laboratory workflows where researchers need a combined GHRH analogue and GHSR-pathway peptide reference material. Component-level identity, purity, and batch documentation should be reviewed through the associated COA before use.
This product is supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. It is not intended for human or animal use.




